Angel Studios, Inc 10-Q for FY2023 Q2
Angel Studios, Inc. (ANGX)
About this 10-Q
Angel Studios, Inc filed this 10-Q on October 5, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net income
- $1.66M
- down 50.8% from net income of $3.37M a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission File Number
(Exact name of registrant as specified in its charter)
|
|
| |
|
|
Registrant’s telephone number, including area code: (
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading |
| Name of each exchange on which |
| | The | ||
| | The | ||
| | The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
☐ | Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 5, 2023, there were
TABLE OF CONTENTS
i
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
SOUTHPORT ACQUISITION CORPORATION
CONDENSED BALANCE SHEETS
| | June 30, 2023 | | December 31, | ||
|
| (unaudited) |
| 2022 | ||
ASSETS |
| |
|
| |
|
Current Assets: |
| |
|
| |
|
Cash | | $ | | | $ | |
Prepaid expenses | |
| — | |
| |
Total Current Assets | |
| | |
| |
Non-Current Assets: | | | | | | |
Marketable securities held in Trust Account | |
| | |
| |
Total Non-current Assets | | | | | | |
TOTAL ASSETS | | $ | | | $ | |
| | | | | | |
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT | |
|
| |
|
|
Current liabilities: | |
|
| |
|
|
Accrued expenses | | $ | | | $ | |
Accounts payable | |
| | |
| |
Accrued offering costs | |
| | |
| |
Due to related party | | | | | | |
Share redemptions payable | | | | | | |
Total Current Liabilities | |
| | |
| |
Non-current liabilities: | |
| | |
| |
Warrant liability | |
| | |
| |
Total Non-current Liabilities | |
| | |
| |
TOTAL LIABILITIES | |
| | |
| |
| | | | | | |
Commitments and Contingencies (Note 8) | |
|
| |
|
|
| | | | | | |
Class A common stock subject to possible redemption; | |
| | |
| |
| | | | | | |
Stockholders’ Deficit | |
| | |
| |
Preferred stock, $ | |
| |
| ||
Class A common stock, $ | |
| | |
| — |
Class B common stock, $ | |
| | |
| |
Additional paid-in capital | |
| — | |
| — |
Accumulated deficit | |
| ( | |
| ( |
Total Stockholders’ Deficit | |
| ( | |
| ( |
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT | | $ | | | $ | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
1
SOUTHPORT ACQUISITION CORPORATION
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
| | For the Three Months | | For the Six Months | ||||||||
| | Ended | | Ended | ||||||||
| | June 30, | | June 30, | ||||||||
|
| 2023 |
| 2022 |
| 2023 |
| 2022 | ||||
Operating costs: | | | | | | | | | | | | |
Insurance expense | | $ | | | $ | | | $ | | | $ | |
Administrative expense | |
| | |
| | | | | |
| |
Legal and accounting expenses | |
| | |
| | | | | |
| |
Franchise tax expense | |
| | |
| | | | | |
| |
Listing fees | | | | | | | | | | | | |
Bank fees | |
| | |
| | | | | |
| |
Total expenses | |
| | |
| | | | | |
| |
Loss from operations | |
| ( | |
| ( | | | ( | |
| ( |
| | | | | | | | | | | | |
Other income (loss): | |
|
| |
| | | | | |
| |
Change in fair value of warrant liability | |
| | |
| | | | ( | |
| |
Financing expense | | | ( | | | — | | | ( | | | — |
Dividend income on marketable securities held in Trust Account | | | | | | | | | | | | |
Other income | | | | | | | | | | | | |
Income before provision for income taxes | | | | | | | | | | | | |
Provision for income taxes | | | ( | | | — | | | ( | | | — |
Net income | | $ | | | $ | | | | | | | |
| | | | | | | | | | | | |
Weighted average shares outstanding of redeemable Class A common stock | |
| | |
| | | | | |
| |
| | | | | | | | | | | | |
Basic and diluted net income per share, redeemable Class A common stock (see Note 2) | | | | | | | | | | | ||
| | | | | | | | | | | | |
Weighted average shares outstanding of non-redeemable Class A and Class B common stock | |
| |
| | | | | |
| | |
| | | | | | | | | | | | |
Basic and diluted net (loss) income per share, non-redeemable Class A and Class B common stock (see Note 2) | | ( | | | | | ( | | | | ||
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
SOUTHPORT ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
(UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023
|
| Class A common stock | | | | | | | | | | | | | | | | | | | | | |||
| | Subject to possible | | | | | | | | | | | | | Additional | | | | | Total | |||||
| | Redemption | | | Class A common stock | | Class B common stock | | Paid-in | | Accumulated | | Stockholders’ | ||||||||||||
| | Shares |
| | Amount |
|
| Shares |
| Amount | | Shares |
| Amount |
| Capital |
| Deficit |
| Deficit | |||||
Balance – January 1, 2023 |
| | | $ | | | | — | | $ | — | | | | $ | | | $ | — | | $ | ( | | $ | ( |
Remeasurement of Class A common stock subject to possible redemption |
| — | |
| | | | — | | | — | | — | |
| — | | | — | |
| ( | |
| ( |
Net income | | — | | | — | | | — | | | — | | — | | | — | | | — | | | | | | |
Balance – March 31, 2023 (unaudited) | | | | | | | | — | | | — | | | | | | | | — | | | ( | | | ( |
Sponsor conversion of Class B common stock | | — | | | — | | | | | | | | ( | | | ( | | | — | | | — | | | — |
Sponsor capital contribution for non-redemption agreements | | — | | | — | | | — | | | — | | — | | | — | | | | | | — | | | |
Redemption of Class A common stock | | ( | | | ( | | | — | | | — | | — | | | — | | | — | | | — | | | — |
Remeasurement of Class A common stock subject to possible redemption | | — | | | | | | — | | | — | | — | | | — | | | ( | | | ( | | | ( |
Net income |
| — | |
| — | | | — | | | — | | — | |
| — | | | — | |
| | |
| |
Balance – June 30, 2023 (unaudited) |
| | | $ | | | | | | $ | | | | | $ | | | $ | — | | $ | ( | | $ | ( |
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022
| | Class A common stock | | | | | | | | | | | | | | | | | | | | | |||
| | Subject to possible | | | | | | | | | | | | | Additional | | | | | Total | |||||
| | Redemption | | | Class A common stock | | Class B common stock | | Paid-in | | Accumulated | | Stockholders’ | ||||||||||||
|
| Shares |
| | Amount |
|
| Shares |
| | Amount |
| Shares |
| | Amount |
| Capital |
| Deficit |
| Deficit | |||
Balance – January 1, 2022 | | | | $ | | | | — | | $ | — | | | | $ | | | $ | — | | $ | ( | | $ | ( |
Remeasurement of Class A common stock subject to possible redemption |
| — | |
| | |
| — | |
| — | | — | |
| — | |
| — | |
| ( | |
| ( |
Net income |
| — | |
| — | |
| — | |
| — | | — | |
| — | |
| — | |
| | |
| |
Balance – March 31, 2022 (unaudited) |
| | | | | |
| — | | | — | | | | | | | $ | — | | | ( | | | ( |
Remeasurement of Class A common stock subject to possible redemption | | — | | | | | | — | | | — | | — | | | — | | | — | | | ( | | | ( |
Net income | | — | | | — | | | — | | | — | | — | | | — | | | — | | | | | | |
Balance – June 30, 2022 (unaudited) | | | | $ | | | | — | | $ | — | | | | $ | | | $ | — | | $ | ( | | $ | ( |
The accompanying notes are an integral part of these unaudited condensed financial statements.
3
SOUTHPORT ACQUISITION CORPORATION
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| | For the Six Months | ||||
| | Ended | ||||
| | June 30, | ||||
| | 2023 | | 2022 | ||
Cash Flows Used in Operating Activities: |
| |
| | ||
Net income | | $ | | | $ | |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |
| | |
| |
Accrued dividend on marketable securities held in Trust Account | | | ( | | | ( |
Change in fair value of warrant liabilities | |
| | |
| ( |
Sponsor capital contribution for non-redemption agreements | | | | | | |
Changes in operating assets and liabilities: | |
| | |
| |
Accounts payable and accrued expenses | |
| | |
| |
Accrued offering costs | |
| — | |
| ( |
Due to related party | | | | | | — |
Prepaid expenses | |
| | |
| ( |
Net cash provided by (used in) operating activities | |
| | |
| ( |
| | | | | | |
Cash Flow Used in Investing Activities: | | | | | | |
Purchases of marketable securities held in Trust Account | | | ( | | | ( |
Proceeds from marketable securities held in Trust Account | | | | | | — |
Net cash used in investing activities | | | ( | | | ( |
| | | | | | |
Cash Flows from Financing Activities: | |
| | |
| |
Repayment of amounts due from related party | |
| — | |
| |
Payments made by related party on behalf of the Company | | | — | | | |
Net cash provided by financing activities | |
| — | |
| |
| | | | | | |
Net Change in Cash | |
| | |
| ( |
Cash – Beginning of period | |
| | |
| |
Cash – End of period | | $ | | | $ | |
| | | | | | |
Supplemental Non-Cash Investing and Financing Activities: | |
| | |
| |
Remeasurement of Class A common stock subject to possible redemption | | $ | | | $ | |
Share redemptions payable | | $ | | | $ | — |
Excess fair value of Class B common stock transferred by Sponsor | | $ | | | $ | — |
Supplemental Cash Flow Information: | | | | | | |
Cash paid for taxes | | $ | — | | $ | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
SOUTHPORT ACQUISTION CORPORATION
NOTES TO THE FINANCIAL STATEMENTS
(UNAUDITED)
Note 1.Description of Organization and Business Operations
Southport Acquisition Corporation (the “Company”) is a blank check company formed in Delaware on April 13, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2023, the Company had not yet commenced any operations. All activity from inception through June 30, 2023 related to the Company’s formation, initial public offering (the “IPO”), and pursuit of a target company to effect a business combination.
The registration statement for the Company’s IPO was declared effective on December 9, 2021. On December 14, 2021, the Company consummated the IPO, which involved the Company’s sale of
Following the closing of the IPO on December 14, 2021, $
Prior to the Special Meeting, on May 25, 2023, the Company and the Sponsor entered into voting and non-redemption agreements (the “Non-Redemption Agreements”) with unaffiliated third parties in exchange for such third parties agreeing (i) not to redeem an aggregate of
5
initial business combination at or prior to such date, in each case, if such third parties continue to hold such Non-Redeemed Shares through the Special Meeting.
In connection with the Special Meeting and the entry into the Non-Redemption Agreements, on May 25, 2023, pursuant to the terms of the amended and restated certificate of incorporation of the Company, the Sponsor converted
In connection with the vote to approve the Extension Amendment Proposal, the holders of
Risks and Uncertainties
Management is currently evaluating the impact of the Russia-Ukraine war, rising interest rates and increased inflation, and recent proposals by the Securities and Exchange Commission (the “SEC”) for new rules and amendments affecting special purpose acquisition corporations like the Company and has concluded that while it is reasonably possible that such matters could have a negative effect on the Company’s financial position, cash flows, results of its operations and/or search for a target company, the specific impacts are not readily determinable as of June 30, 2023. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Going Concern
As of June 30, 2023 and December 31, 2022, the Company had cash of $
Note 2.Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
6
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC on May 30, 2023, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $
7
Marketable Securities Held in Trust Account
Following the closing of the IPO on December 14, 2021, an amount of $
In connection with the vote to approve the Extension Amendment Proposal, the holders of
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement” (“ASC 820”), approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. As of June 30, 2023 and December 31, 2022, derivative liabilities are comprised of the warrant liability of $
8
Warrant Liability
The Company accounts for warrants for the Company’s common stock that are not indexed to its own shares as liabilities at fair value on the balance sheet. The warrants are subject to remeasurement at each balance sheet date and any change in fair value is recognized as a component of other income (expense), net on the statement of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the common stock warrants. At that time, the portion of the warrant liability related to the common stock warrants will be reclassified to additional paid-in capital.
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022,
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit. On June 9, 2023, the holders of
The share redemptions payable was recorded as of June 30, 2023 to reflect the June 9, 2023 redemptions that were not processed by the Trustee until July 7, 2023. As the holders properly exercised their right to redeem their shares for cash on June 9, 2023, the value of Class A common stock subject to possible redemption should be decreased by the $
As of June 30, 2023 and December 31, 2022, the Class A common stock, classified as temporary equity in the condensed balance sheets, are reconciled in the following tables:
| | | |
Gross proceeds from initial public offering |
| $ | |
Less: | |
| |
Proceeds allocated to public warrants | |
| ( |
Offering costs allocated to Class A common stock subject to possible redemption | |
| ( |
Add: | |
| |
Remeasurement of Class A common stock subject to possible redemption | |
| |
Class A common stock subject to possible redemption, December 31, 2021 | | | |
Remeasurement of Class A common stock subject to possible redemption | |
| |
Class A common stock subject to possible redemption, December 31, 2022 | | | |
Remeasurement of Class A common stock subject to possible redemption | | | |
Class A common stock subject to possible redemption, March 31, 2023 | | $ | |
Share redemptions payable | | | ( |
Remeasurement of Class A common stock subject to possible redemption | | | |
Class A common stock subject to possible redemption, June 30, 2023 | | $ | |
9
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were
Net Income (Loss) Per Common Stock
The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share”. The condensed statements of operations include a presentation of income per Class A redeemable common stock and income (loss) per non-redeemable common stock following the two-class method of income per common stock. In order to determine the net income (loss) attributable to both the Class A redeemable common stock and non-redeemable common stock, the Company first considered the total income allocable to both sets of stock. This is calculated using the total net income less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the Class A common stock subject to possible redemption was treated as dividends paid to the public stockholders. Subsequent to calculating the total income (loss) allocable to both sets of stock, the Company split the amount to be allocated using the weighted average shares outstanding ratio for the Class A redeemable common stock and for the non-redeemable Class A and Class B common stock for the three and six months ended June 30, 2023 as a result of shareholder redemptions. For the three and six months ended June 30, 2023, the Company split the amount to be allocated using a ratio of
The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts):
|
| For the Three Months Ended | |
| | June 30, 2023 | |
Net income | | $ | |
Less: Remeasurement of Class A redeemable shares to redemption value | |
| ( |
Net income excluding accretion of Class A redeemable shares to redemption value | | $ | ( |
10
| | For the Three Months Ended | | | |
| ||||
| | June 30, 2023 | | | |
| ||||
| | Class A | | Class A and Class B | | | | | ||
|
| Redeemable Shares |
| Non-redeemable shares |
| Total |
| |||
Total number of shares | | | | | | | | | | |
Weighted average shares ratio |
| | | % | | | % | | | % |
| | | | | | | | | | |
Net income allocated based on weighted average shares ratio | | $ | | | $ | | | $ | | |
| | | | | | | | | | |
Less: Accretion allocation based on weighted average shares ratio | |
| ( | |
| ( | |
| ( | |
Plus: Accretion applicable to Class A redeemable shares | |
| | |
| — | |
| | |
Total income (loss) based on weighted average shares ratio | | $ | | | $ | ( | | $ | | |
| | | | | | | | | | |
Weighted average shares outstanding | |
| | |
| | |
|
| |
Basic and diluted net income (loss) per share | | $ | | | $ | ( | |
|
| |
|
| For the Six Months Ended | |
| | June 30, 2023 | |
Net income | | $ | |
Less: Remeasurement of Class A redeemable shares to redemption value | |
| ( |
Net income excluding accretion of Class A redeemable shares to redemption value | | $ | ( |
| | For the Six Months Ended | | | |
| ||||
| | June 30, 2023 | | | |
| ||||
| | Class A | | Class A and Class B | | | | | ||
|
| Redeemable Shares |
| Non-redeemable shares |
| Total |
| |||
Total number of shares | | | | | | | | | | |
Weighted average shares ratio |
| | | % | | | % | | | % |
| | | | | | | | | | |
Net income allocated based on weighted average shares ratio |
| $ | |
| $ | |
| $ | | |
| | | | | | | | | | |
Less: Accretion allocation based on weighted average shares ratio |
| | ( |
| | ( |
| | ( | |
Plus: Accretion applicable to Class A redeemable shares |
| | |
| | — |
| | | |
Total income (loss) based on weighted average shares ratio | | $ | | | $ | ( | | $ | | |
| | | | | | | | | | |
Weighted average shares outstanding | |
| | |
| | |
|
| |
Basic and diluted net income (loss) per share | | $ | | | $ | ( | |
|
| |
| | | |
|
| For the Three | |
| | Months Ended | |
| | June 30, 2022 | |
Net income | | $ | |
Less: Remeasurement of Class A redeemable shares to redemption value | |
| ( |
Net income excluding accretion of Class A redeemable shares to redemption value | | $ | |
| | | | | | | | | | |
| | For the Three Months Ended | | | |
| ||||
| | June 30, 2022 | | | |
| ||||
11
|
| Class A |
| Class A and Class B |
| Total | | |||
Total number of shares | | | | | | | | | | |
Ownership percentage |
| | | % | | | % | | | % |
| | | | | | | | | | |
Net income allocated based on ownership percentage |
| | |
| | |
| | | |
| | | | | | | | | | |
Less: Accretion allocation based on ownership percentage |
| | ( |
| | ( |
| | ( | |
Plus: Accretion applicable to Class A redeemable shares |
| | |
| | — |
| | | |
Total income based on ownership percentage | | $ | | | $ | | | $ | | |
| | | | | | | | | | |
Weighted average shares outstanding | |
| | |
| | |
|
| |
Basic and diluted net income per share | | $ | | | $ | | |
|
| |
| | | |
|
| For the Six | |
| | Months Ended | |
| | June 30, 2022 | |
Net income | | $ | |
Less: Remeasurement of Class A redeemable shares to redemption value | |
| ( |
Net income excluding accretion of Class A redeemable shares to redemption value | | $ | |
| | For the Six Months Ended | | | |
| ||||
| | June 30, 2022 | | | |
| ||||
| | Class A | | Class A and Class B | | | | | ||
|
| Redeemable Shares |
| Non-redeemable shares |
| Total | | |||
Total number of shares | | | | | | |
| | | |
Ownership percentage |
| | | % | | | % | | | % |
| | | | | | | | | | |
Net income allocated based on ownership percentage |
| | |
| | |
| | | |
| | | | | | | | | | |
Less: Accretion allocation based on ownership percentage |
| | ( |
| | ( |
| | ( | |
Plus: Accretion applicable to Class A redeemable shares |
| | |
| | — |
| | | |
Total income based on ownership percentage | | $ | | | $ | | | $ | | |
| | | | | | | | | | |
Weighted average shares outstanding | |
| | |
| | |
|
| |
Basic and diluted net income per share | | $ | | | $ | | |
|
| |
Related Parties
Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $
12
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. This guidance is effective as of January 1, 2022. The Company evaluated the effect the updated standard has on its financial position, results of operations or financial statement disclosure and determined there is no material impact.
The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on the financial condition based on the current information.
13
Note 3.Initial Public Offering
At the closing of the IPO on December 14, 2021, the Company sold
Upon the closing of the IPO on December 14, 2021, $
Transaction costs of the IPO amounted to $
Note 4.Private Placement
The Sponsor purchased an aggregate of
Each Private Placement Warrant is exercisable for
Note 5.Related Party Transactions
Founder Shares
On May 27, 2021, the Company issued an aggregate of
14
The Sponsor agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Company’s Class A common stock equals or exceeds $
Related Party Loans
The Sponsor agreed to loan the Company an aggregate of up to $
In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $
Due to Related Party
The Sponsor has made tax payments, payments to various vendors on behalf of the Company, and transferred funds to the Company. As of June 30, 2023 and December 31, 2022, the Company owed $
Administrative Support Agreement
Commencing on December 10, 2021 and until completion of the Company’s initial Business Combination or liquidation, the Company is required to pay the Sponsor $
Note 6.Stockholders’ Equity
Preferred stock — The Company is authorized to issue up to
Class A common stock — The Company is authorized to issue up to
15
Class B common stock — The Company is authorized to issue up to
The shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of the Business Combination on a
The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.
Note 7.Warrants
The Company accounts for
Warrants – Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable
The Company is not obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrants are exercisable for cash or on a cashless basis, and the Company is not obligated to issue any shares of Class A common stock to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.
16
The registration statement for the IPO (the “IPO Registration Statement”) registered the sale for the shares of Class A common stock issuable upon exercise of the Public Warrants. The Company has agreed that as soon as practicable, but in no event later than
Redemption of warrants when the price per share of Class A common stock equals or exceeds $
| ● | in whole and not in part; |
| ● | at a price of $ |
| ● | upon a minimum of |
| ● | if, and only if, the last reported sale price of the Class A common stock equals or exceeds $ |
Redemption of warrants when the price per Class A common stock equals or exceeds $
| ● | in whole and not in part; |
| ● | at a price of $ |
| ● | upon a minimum of |
| ● | if, and only if, the last reported sale price of the Class A common stock equals or exceeds $ |
| ● | if the last reported sale price of the Class A common stock for any trading days within a -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $ |
The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the sale of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the -day redemption period (or, in the case of a redemption described above under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $
17
If the Company calls the Public Warrants for redemption, the Company’s management will have the option to require or permit all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $
The Private Placement Warrants are identical to the Public Warrants included in the Units sold in the IPO, except that the Private Placement Warrants and the shares of common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until
If a tender offer, exchange or redemption offer shall have been made to and accepted by the holders of the Class A common stock and upon completion of such offer, the offeror owns beneficially more than 50% of the outstanding Class A common stock, the holder of the warrant shall be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such warrant had been exercised, accepted such offer and all of the Class A common stock held by such holder had been purchased pursuant to the offer. If less than 70% of the consideration receivable by the holders of the Class A common stock in the applicable event is payable in the form of common equity in the successor entity that is listed on a national securities exchange or is quoted in an established over-the-counter market, and if the holder of the warrant properly exercises the warrant within thirty days following the public disclosure of the consummation of the applicable event by the Company, the warrant exercise price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined in the warrant agreement) minus (B) the value of the warrant based on the Black-Scholes Warrant Value for a Capped American Call on Bloomberg Financial Markets.
The Company expects to account for the Public Warrants and Private Placement Warrants as liabilities in accordance with the guidance contained in ASC 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity”. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the stockholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability.
Additionally, certain adjustments to the settlement amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815-40, and thus the Private Placement Warrants are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting.
18
The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the issuance of the warrants at the closing of this offering. Accordingly, the Company classifies each warrant as a liability at its fair value. The Public Warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined with the assistance of a professional independent valuation firm. The warrant liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. The Company reassess the classification of the warrants at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification. There has been no change in the classification of the warrants as of June 30, 2023.
Note 8.Commitments and Contingencies
Registration rights
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of the underlying securities thereof, as applicable) are entitled to registration rights pursuant to a registration rights agreement signed on December 9, 2021, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A common stock). The holders of these securities are entitled to make up to
Underwriting Agreement
The Company granted the underwriter a -day option from the date of the IPO to purchase up to
Non-redemption Agreements
On May 25, 2023, the Company and the Sponsor entered into Non-Redemption Agreements with unaffiliated third parties in exchange for such third parties agreeing (i) not to redeem an aggregate of
The Company accounted for the Non-Redemption Agreements in accordance with Staff Accounting Bulletin Topic 5T (“SAB Topic 5T”). The Company considered the Sponsor’s transfer of Class B common stock to the unaffiliated third parties in exchange for the Non-Redemption Agreements as a capital contribution by the Sponsor, and recognized the excess fair value of the transferred Class B common stock as a financing expense on the condensed statements of operations for the three and six months ended June 30, 2023. The Company determined the excess fair value of the
19
Note 9.Fair Value Measurements
Recurring Fair Value Measurments
The following table presents information about the Company’s assets and liabilities that are measured at fair value at June 30, 2023, and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| | June 30, 2023 | |||||||
|
| (Level 1) |
| (Level 2) |
| (Level 3) | |||
Assets: |
| |
|
| |
|
| |
|
Marketable securities held in trust account | | $ | | | $ | — | | $ | — |
Liabilities: | |
| | |
| | |
|
|
Share redemptions payable | | $ | | | $ | — | | $ | — |
Public Warrants | | $ | | | $ | — | | $ | — |
Private Placement Warrants | | $ | — | | $ | | | $ | — |
| | December 31, 2022 | |||||||
|
| (Level 1) |
| (Level 2) |
| (Level 3) | |||
Assets: | |
|
| |
|
| |
|
|
Marketable securities held in trust account |
| $ | |
| $ | — |
| $ | — |
Liabilities: | |
| | |
| | |
| |
Share redemptions payable | | $ | — | | $ | — | | $ | — |
Public Warrants |
| $ | |
| $ | — |
| $ | — |
Private Placement Warrants |
| $ | — |
| $ | |
| $ | — |
At June 30, 2023, and December 31, 2022, the Company’s warrant liability was valued at $
The following table presents fair value information for the three and six months ended June 30, 2023, and 2022, of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value.
| | For the Three and Six Months Ended June 30, 2023 | ||||||||||
| | | | Private | | | | | Share | |||
| | Public | | Placement | | Warrant | | Redemptions | ||||
|
| Warrants |
| Warrants |
| Liability |
| Payable | ||||
Derivative warrant liabilities as of December 31, 2022 | | $ | | | $ | | | $ | | | $ | — |
Change in fair value | |
| | |
| | |
| | | | — |
Derivative warrant liabilities as of March 31, 2023 | | | |
| | |
| | | | | — |
Establishment of share repurchase liability | | | — | | | — | | | — | | | |
Change in fair value | | | ( | | | ( | | | ( | | | — |
Derivative warrant liabilities as of June 30, 2023 | | $ | | | $ | | | $ | | | $ | |
20
| | | | | | | | | | | | |
| | For the Three and Six Months Ended June 30, 2022 | ||||||||||
| | | | Private | | | | | Share | |||
| | Public | | Placement | | Warrant | | Redemptions | ||||
|
| Warrants |
| Warrants |
| Liability |
| Payable | ||||
Derivative warrant liabilities as of December 31, 2021 | | $ | | | $ | | | $ | | | $ | — |
Change in fair value | |
| ( | |
| ( | |
| ( | | | — |
Derivative warrant liabilities as of March 31, 2022 | | | |
| | |
| | | | | — |
Change in fair value | | | ( | | | ( | | | ( | | | — |
Derivative warrant liabilities as of June 30, 2022 | | $ | | | $ | | | $ | | | $ | — |
Measurement
The Company established the initial fair value for the warrants on December 14, 2021, the date of the consummation of the Company’s IPO. The Company used a Black-Scholes-Merton formula to value the warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-half of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B common stock, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A common stock subject to possible redemption (temporary equity), Class A common stock (permanent equity) and Class B common stock (permanent equity) based on their relative fair values at the initial measurement date. As of June 30, 2023, the public warrants have detached from the Units and are separately tradable on the New York Stock Exchange (PORT.W). The closing price of the public warrants was utilized in determining the fair value of the public warrants as of June 30, 2023.
The key inputs into the lattice model and Monte Carlo simulation model formula to fair value the private placement warrants were as follows at June 30, 2023 and 2022:
|
| | |
| |
| |
| | June 30, | | ||||
Inputs: |
| 2023 |
| 2022 |
| ||
Common stock price | | $ | | | $ | |
|
Exercise price | | $ | | | $ | | |
Risk-free rate of interest | |
| | % |
| | % |
Volatility | |
| | % |
| | % |
Term | |
| | |
| | |
Warrant to buy one share | | $ | | | $ | | |
Dividend yield | |
| | % |
| | % |
21
Non-recurring Fair Value Measurements
On May 25, 2023, the Company and the Sponsor entered into Non-Redemption Agreements with unaffiliated third parties (see Note 8). The Company accounts for the excess fair value of the Class B shares transferred from the Sponsor to the unaffiliated third parties as a capital contribution by the Sponsor and recorded a financing expense in accordance with SAB Topic 5T. The Company estimated the fair value of the
The fair value of the Class B shares was determined by multiplying the underlying stock price of the Company’s Class A common stock by the estimated probability of an Initial Business Combination and applying a discount for lack of marketablility (“DLOM”). The Company utilized June 9, 2023, the date of the consummation of the Extension, as the measurement date.
The following are the key inputs into the calculation at the measurement date:
|
| June 9, |
| |
Inputs: | | 2023 |
| |
Common stock price | | $ | | |
Estimated probability of an Initial Business Combination | |
| | % |
Estimated volatility | |
| | % |
Risk-free rate | |
| | % |
Time to expiration | |
| | |
Note 10.Income Taxes
The Company utilized the discrete method for estimating its interim income tax provision. During the three and six months ended June 30, 2023, the Company recorded an income tax provision of $
The Company has evaluated the positive and negative evidence bearing upon its ability to realize its deferred tax assets, which primarily consist of capitalized startup costs. The Company considered the history of cumulative net losses, estimated future taxable income and prudent and feasible tax planning strategies, and has concluded that it is more likely than not that the Company will not realize the benefits of its deferred tax assets. As such, the Company recorded a full valuation allowance against net deferred tax assets as of June 30, 2023.
Note 11. Subsequent Events
On July 7, 2023, the Trustee processed the June 9, 2023 redemptions of
On August 22, 2023, the Company received notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with th NYSE’s continued listing requirements under the timely filing criteria set forth in Section 802.01E of the NYSE Listed Company Manual since the Company did not file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 with the SEC on or before August 21, 2023, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended. The NYSE informed the Company that, under the NYSE’s rules, the Company can regain compliance with the NYSE’s continued listing requirements by filing the Form 10-Q with the SEC at any time prior to February 21, 2024.
On September 11, 2023, the Board approved the extension of the date by which the Company must consummate an initial business combination from September 14, 2023 to October 14, 2023 (the “First Extension”). The First Extension is the first of six one-month extensions permitted under the Company’s Amended and Restated Certificate of Incorporation.
22
In connection with the First Extension, the Sponsor, transferred
23
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless otherwise stated or the context otherwise requires, references in this quarterly report to (i) the “Company,” “us” or “we” are to Southport Acquisition Corporation, a Delaware corporation; (ii) “founder shares” are to shares of our Class B common stock initially purchased by our sponsor in a private placement prior to our IPO (as defined herein), and the shares of our Class A common stock issued upon the conversion thereof; and (iii) “sponsor” are to Southport Acquisition Sponsor LLC, a Delaware limited liability company. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This quarterly report, including statements under this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not a forward-looking statement. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying some of the important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the discussion under the headings “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors” in our annual report on Form 10-K for the fiscal year ended December 31, 2022 and our quarterly report on Form 10-Q for the quarter ended March 31, 2023 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated as a Delaware corporation on April 13, 2021 and formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not identified any business combination target. We intend to effectuate our initial business combination using cash from the proceeds from our IPO and the Private Placement, our capital stock, debt or a combination of cash, capital stock and debt.
On December 14, 2021, we consummated our initial public offering (our “IPO”) of 23,000,000 units (the “units”), each unit consisting of one share of Class A common stock of the Company, par value $0.0001 per share (the “Class A Common Stock”) and one-half of one warrant of the Company, each whole warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share (subject to adjustment). The 23,000,000 units sold in our IPO include 3,000,000 units sold to BofA Securities, Inc., the underwriter for our IPO (the “underwriter”), pursuant to the underwriter’s full exercise of its option under the underwriting agreement for our IPO to purchase up to 3,000,000 additional units solely to cover over-allotments. The units were sold at a price of $10.00 per unit, and our IPO generated gross proceeds of $230,000,000. Simultaneously with the closing of our IPO, we consummated a private placement (the “Private Placement”) with our sponsor of an aggregate of 11,700,000 warrants (the “private placement warrants”) at a price of $1.00 per private placement warrant, generating gross proceeds to the Company of $11,700,000.
On December 14, 2021, a total of $234,600,000 of the net proceeds from our IPO and the Private Placement were deposited in a trust account (the “Trust Account”) established for the benefit of the Company’s public stockholders at JPMorgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company, acting as trustee. The net proceeds deposited into the Trust Account remain on deposit in the Trust Account earning interest and are available for a business combination, assuming no redemptions, before fees and expenses associated with our initial business combination.
24
Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay our tax obligations (less up to $100,000 of interest to pay dissolution expenses), the proceeds deposited in the Trust Account will not be released from the Trust Account until the earliest of (a) the completion of our initial business combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our amended and restated certificate of incorporation (i) to modify the substance or timing of our obligation to provide our public stockholders the right to have their public shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination by June 14, 2023 or during any extended time we have to consummate our initial business combination beyond June 14, 2023 as a result of a stockholder vote to amend our amended and restated certificate of incorporation (an “Extension Period”) or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, and (c) the redemption of all of our public shares if we are unable to complete our initial business combination by June 14, 2023 or during any Extension Period, subject to applicable law. The proceeds held in the Trust Account may only be invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations.
On June 9, 2023, the Company’s stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation (the “Extension Amendment Proposal”) to extend the time that the Company has to consummate its initial business combination from June 14, 2023 to September 14, 2023 (the “Extended Date”) and to allow the board of directors of the Company, without another stockholder vote, to elect to further extend the date to consummate an initial business combination after the Extended Date up to six times, by an additional month each time, up to March 14, 2024, providing the Company a 21-month period (or up to 27-month period) from the closing of the IPO to consummate its initial Business Combination.
As of June 30, 2023, we had not yet commenced any operations. All activity from inception through June 30, 2023 relates to our formation, our IPO and our pursuit of a target company with which to effect our initial business combination. The Company has selected December 31 as its fiscal year end.
Results of Operations and Known Trends or Future Events
Our entire activity from inception through June 30, 2023 relates solely to our formation, our IPO and, since the closing of our IPO, a search for a business combination candidate. We have not generated any operating revenues to date, and we will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. We have incurred and expect to continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended June 30, 2023, we had net income of $1,657,247, which consisted of $2,864,209 dividend income on marketable securities held in the Trust Account, and a gain of $141,150 on the change in fair value of the warrant liability, offset by a $386,961 financing expense related to the excess fair value of Class B common stock transferred by the Sponsor, provision for income tax of $591,012, $78,770 in legal and accounting expenses, $49,863 of franchise tax expense, $98,532 of insurance expense, $98,311 of administrative expenses, $42,500 of listing fees, and $2,163 of bank fees.
For the six months ended June 30, 2023, we had net income of $2,841,712, which consisted of $5,389,508 dividend income on marketable securities held in the Trust Account, offset by a loss of $400,950 on the change in fair value of the warrant liability, a $386,961 financing expense related to the excess fair value of Class B common stock transferred by the Sponsor, provision for income tax of $1,110,969, $155,441 in legal and accounting expenses, $99,178 of franchise tax expense, $227,594 of insurance expense, $120,403 of administrative expenses, $42,500 of listing fees, and $3,800 of bank fees.
For the three months ended June 30, 2022, we had net income of $3,371,189, which consisted of a $3,427,000 gain on the change in fair value of warrant liabilities and $310,960 of dividend income on marketable securities held in the Trust Account, offset by $83,098 in legal and accounting expenses, $49,863 of franchise tax expense, $129,063 of insurance expense, $90,124 of listing fees, and $14,623 of administrative expenses and bank fees expenses.
For the six months ended June 30, 2022, we had net income of $13,741,030, which consisted of a $14,279,000 gain on the change in fair value of warrant liabilities and $333,264 of dividend income on marketable securities held in the Trust Account, offset by
25
$347,128 in legal and accounting expenses, $99,178 of franchise tax expense, $258,125 of insurance expense, $90,124 of listing fees, and $76,679 of administrative expenses and bank fees expenses.
Liquidity and Capital Resources
As of June 30, 2023 and December 31, 2022, we had cash of $461,464 and $50,858, respectively, and working capital deficit of $199,924,069 and $929,527, respectively.
As of June 30, 2023, net cash provided by operating activities was $4,334,318. Net income of $2,841,712 was increased by a $400,950 loss on the fair value of the warrant liability, a $386,961 non-cash financing expense related to the transfer of Class B shares by the Sponsor, and a $1,710,491 increase in changes in operating assets and liabilities, offset by a decrease for $1,005,796 of accrued dividends on marketable securities held in the Trust Account.
As of June 30, 2022, net cash used in operating activities was $1,541,262. Net income of $13,741,030 was decreased by a $14,279,000 gain on the fair value of the warrant liability, $1,005,796 of accrued dividends on marketable securities held in the Trust Account, and a $846,818 decrease in changes in operating assets and liabilities.
As of June 30, 2023, net cash used in investing activities was $3,923,712, comprised of purchases of marketable securities held in the Trust Account of $4,383,712, offset by proceeds from marketable securities held in the Trust Account of $460,000. As of June 30, 2022, net cash used in investing activities was $176,790 comprised of purchases of marketable securities held in the Trust Account.
As of June 30, 2023, there was no net cash provided by financing activities. As of June 30, 2022, net cash provided by financing activities was $240,131, comprised of $156,550 of payments made by the Sponsor on behalf of the Company and receipt of $83,581 repayment for due from related party balance.
We expect to use our working capital primarily for legal and accounting fees related to our regulatory reporting requirements, fees for office space, utilities, and secretarial and administrative services, continued listing fees on the New York Stock Exchange (“NYSE”), and for expenses in connection with identifying and evaluating target businesses, performing business due diligence on prospective target businesses, travelling to and from the offices or similar locations of prospective target businesses or their representatives or owners, reviewing corporate documents and material agreements of prospective target businesses and structuring, negotiating and completing a business combination.
Specifically, we expect that our primary liquidity requirements over the next 12 months from June 30, 2023 will include, among other things, approximately $180,000 for office space, utilities, and secretarial and administrative services pursuant to our agreement with our sponsor to pay our sponsor $15,000 per month for these services until our initial business combination or liquidation; $300,000 for legal, accounting, due diligence, travel and other expenses in connection with any business combination; $300,000 for legal and accounting fees related to regulatory reporting requirements; $85,000 for NYSE continued listing fees; and approximately $200,000 for working capital to cover miscellaneous expenses (including Delaware franchise taxes, net of anticipated interest income). These amounts are estimates and may differ materially from our actual expenses.
In light of the above, our management does not expect that we will be able to fund our liquidity requirements in the next 12 months from our current working capital. In order to fund the expected working capital deficiency or to finance transaction costs in connection with an intended initial business combination, our management plans to seek loans from our management team or our sponsor or any of their respective affiliates. However, neither our management team nor our sponsor or their respective affiliates are obligated to loan us these funds, and, as such, there is no assurance that we will be able to obtain sufficient loans to fund any working capital deficiency. If we receive such loans, up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. These warrants would be identical to the private placement warrants.
These conditions raise substantial doubt about our ability to continue as a going concern for a period of time within 12 months from June 30, 2023.
Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. In addition, we may target businesses
26
with enterprise values that are greater than we could acquire with the net proceeds from our IPO and the Private Placement, and, as a result, if the cash portion of the purchase price exceeds the amount available from the Trust Account, net of amounts needed to satisfy redemptions by public stockholders, we may be required to seek additional financing to complete such proposed initial business combination.
If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account.
On May 25, 2023, pursuant to the terms of the amended and restated certificate of incorporation of the Company, the Sponsor converted 4,200,000 shares of the Company’s Class B common stock held by it on a one-for-one basis into shares of the Company’s Class A common stock, resulting in an aggregate of 27,200,000 shares of Class A common stock issued and outstanding, comprised of 4,200,000 shares of Class A common stock held by the Sponsor and not subject to possible redemption and 23,000,000 shares of Class A common stock subject to possible redemption. On June 9, 2023, the holders of 18,849,935 shares of Class A common stock properly exercised their right to redeem their shares in connection with the vote on the Extension Amendment Proposal for $197,694,657 in cash, resulting in 4,150,065 shares of Class A common stock issued and outstanding that are subject to possible redemption.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023 or December 31, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities as of June 30, 2023 or December 31, 2022.
Pursuant to the underwriting agreement for our IPO, the underwriter of our IPO was entitled to a deferred fee of $0.35 per unit, or $8,050,000 in the aggregate, payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement. However, on August 22, 2022, the underwriter delivered a letter to the Company pursuant to which the underwriter waived its entitlement to the payment of the deferred underwriting fee.
We have entered into a letter agreement with our sponsor pursuant to which we are required to pay our sponsor a total of $15,000 per month for office space, utilities, and secretarial and administrative services, commencing on December 10, 2021, the date that our securities were first listed on the NYSE, through the earlier of our initial business combination and our liquidation.
Commitments and Contingencies
Registration rights
The holders of the founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans (and in each case holders of the underlying securities thereof, as applicable) are entitled to registration rights pursuant to a registration rights agreement signed on December 9, 2021, requiring the Company to register such securities for resale (in the case of the founder shares, only after conversion to our Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of a business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”). However, the registration rights agreement provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period with respect to such securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
27
Underwriting Agreement
We granted the underwriter a 45-day option from the date of our IPO to purchase up to 3,000,000 additional units to cover over-allotments, if any, at the IPO price less the underwriting discount. On December 13, 2021, the underwriter exercised the option in full, closing the sale of the 3,000,000 additional units on December 14, 2021. The underwriter was paid an underwriting commission of $4,600,000 upon the closing of our IPO. In addition, the underwriter was entitled to a deferred fee of $0.35 per unit, or $8,050,000 in the aggregate, payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement.
On August 22, 2022, the underwriter delivered a letter to the Company pursuant to which the underwriter waived its entitlement to the payment of the deferred underwriting fee. The $8,050,000 waived fee was recorded to accumulated deficit.
Non-redemption Agreements
On May 25, 2023, the Company and the Sponsor entered into Non-Redemption Agreements with unaffiliated third parties in exchange for such third parties agreeing (i) not to redeem an aggregate of 4,000,000 shares of Class A common stock sold in its initial public offering (the “Non-Redeemed Shares”) in connection with the Special Meeting and (ii) to vote in favor of the Extension Amendment Proposal and the Extension at the Special Meeting (other than with respect to certain shares acquired or to be acquired pursuant to the Non-Redemption Agreements). In exchange for the foregoing commitments, the Sponsor has agreed to transfer to such third parties an aggregate of up to 1,499,996 shares of Class B common stock held by the Sponsor, with 500,000 of such shares to be transferred to such third parties promptly upon consummation of the Extension, and an additional 166,666 shares to be transferred to such third parties monthly beginning on September 14, 2023 and up to, and including, February 14, 2024, if the board of directors of the Company elects to further extend the deadline to consummate an initial business combination at or prior to such date, in each case, if such third parties continue to hold such Non-Redeemed Shares through the Special Meeting.
The Company accounted for the Non-Redemption Agreements in accordance with Staff Accounting Bulletin Topic 5T (“SAB Topic 5T”). The Company considered the Sponsor’s transfer of Class B common stock to the unaffiliated third parties in exchange for the Non-Redemption Agreements as a capital contribution by the Sponsor, and recognized the excess fair value of the transferred Class B common stock as a financing expense on the condensed statements of operations for the three and six months ended June 30, 2023. The Company determined the excess fair value of the 500,000 Class B shares transferred to such third parties upon the consummation of the Extension to be $386,961.
Critical Accounting Estimates
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting estimates as of June 30, 2023.
Recent Accounting Pronouncements
Refer to Note 2. Summary of Significant Accounting Policies of the Notes to the Financial Statements.
28
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item. The net proceeds from our IPO and the Private Placement held in the Trust Account are invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, such as this report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our Chief Executive Officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current Chief Executive Officer who also acts as our principal accounting officer, the effectiveness of our disclosure controls and procedures as of June 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer concluded that, as of June 30, 2023, our disclosure controls and procedures were not effective due to the previously disclosed material weakness in our internal control over financial reporting related to the fact that the Company has not yet designed and maintained effective controls relating to the presentation of our statement of cash flows.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Remediation Activities
Following the determination of the material weakness, our Chief Financial Officer performed additional post-closing review procedures including consulting with subject matter experts related to the accounting for marketable securities. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements, we have improved, and will continue to improve, these processes to ensure that transactions are effectively evaluated in the context of the increasingly complex accounting standards. We plan to continue to enhance our review procedures of evaluating and implementing the accounting standards that apply to our financial statements, including additional analyses by our personnel and third-party professionals with whom we consult regarding complex accounting. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
29
PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
To the knowledge of our management, there is no material litigation, arbitration or governmental proceeding currently pending against us, any of our officers or directors in their capacity as such or against any of our property.
Item 1A. Risk Factors.
Factors that could cause our actual results to differ materially from those in this quarterly report are any of the risks described in our annual report on Form 10-K for the year ended December 31, 2022 and our quarterly report on Form 10-Q for the quarter ended March 31, 2023 filed with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition.
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our annual report on Form 10-K for the year ended December 31, 2022 and our quarterly report on Form 10-Q for the quarter ended March 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Recent Sales of Unregistered Securities
We did not sell any unregistered equity securities during the quarter ended June 30, 2023.
Use of Proceeds from our IPO
On December 14, 2021, we consummated our IPO of 23,000,000 units, which included 3,000,000 units issued pursuant to the exercise in full by BofA Securities, Inc., the underwriter, of its over-allotment option, which option was granted to the underwriter under the underwriting agreement for our IPO. The units were sold at a price of $10.00 per unit, and our IPO generated gross proceeds of $230,000,000. The securities sold in our IPO were registered under the Securities Act on a registration statement on Form S-1 (No. 333-261370). The SEC declared the registration statement effective on December 9, 2021.
At the time of the consummation of our IPO, we paid a total of $4,600,000 in underwriting fees related to our IPO. In addition, the underwriter agreed to defer $8,050,000 in underwriting fees. On August 22, 2022, the underwriter delivered a letter to the Company pursuant to which the underwriter waived its entitlement to the payment of the deferred underwriting fee.
On December 14, 2021, a total of $234,600,000 of the net proceeds from our IPO and the Private Placement were deposited in the Trust Account. The net proceeds deposited into the Trust Account remain on deposit in the Trust Account and are available for a business combination, assuming no redemptions, before fees and expenses associated with our initial business combination. The proceeds held in the Trust Account will be invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
Through December 14, 2021, we incurred $1,285,218 for other costs and expenses related to our IPO.
In connection with the vote to approve the Extension Amendment Proposal, the holders of 18,849,935 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.49 per share of Class A common stock, for an aggregate redemption amount of $197,694,657. The Trustee redeemed $197,694,657 of marketable securities held in the Trust Account to pay the holders redeeming 18,849,935 shares of Class A common stock on July 7, 2023.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers during the Quarter Ended June 30, 2023
None.
30
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
Exhibit No. |
| Description |
31.1* | | |
32.1** | | |
101.INS* | | XBRL Instance Document |
101.CAL* | | XBRL Taxonomy Extension Calculation Linkbase Document |
101.SCH* | | XBRL Taxonomy Extension Schema Document |
101.DEF* | | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB* | | XBRL Taxonomy Extension Labels Linkbase Document |
101.PRE* | | XBRL Taxonomy Extension Presentation Linkbase Document |
104 | | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
* | Filed herewith |
** | Furnished herewith |
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
October 5, 2023 | Southport Acquisition Corporation | |
| | |
| By: | /s/ Jeb Spencer |
| | Name: Jeb Spencer |
| | Title: Chief Executive Officer (and Principal Financial Officer) |
32
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jeb Spencer, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Southport Acquisition Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | [Paragraph intentionally omitted in accordance with SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313]; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:October 5, 2023 | By: | /s/ Jeb Spencer |
| | Jeb Spencer |
| | Chief Executive Officer |
| | (Principal Executive Officer and Principal Financial Officer) |
EXHIBIT 32.1
CERTIFICATION OF CEO PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Southport Acquisition Corporation (the “Company”) for the quarterly period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Jeb Spencer, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date:October 5, 2023 | By: | /s/ Jeb Spencer |
| | Jeb Spencer |
| | Chief Executive Officer |
| | (Principal Executive Officer and Principal Financial Officer) |